ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,607Medicare Part D Prescriptions Filled, Including Refills

Rank: 296 out of 4623

$627K Total Retail Price of All Prescriptions

Rank: 458 out of 4623

552 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 552 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

22% of this provider’s 552 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,733 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 696 557 S3 1 3
LISINOPRIL 512 463 2 4
FUROSEMIDE 425 390 3 8
OMEPRAZOLE 409 378 4 7
LEVOTHYROXINE SODIUM 396 370 5 1
POTASSIUM CHLORIDE 318 285 6 14
METFORMIN HCL 294 241 7 6
METOPROLOL TARTRATE 287 267 8 9
SIMVASTATIN 273 253 9 2
AMLODIPINE BESYLATE 249 235 10 5
ATENOLOL 223 199 11 28
CITALOPRAM HBR 223 212 11 23
PRAVASTATIN SODIUM 220 199 13 11
WARFARIN SODIUM 214 213 14 24
DIGOXIN 214 208 14 58
GABAPENTIN 204 129 16 16
HYDROCHLOROTHIAZIDE 187 160 17 10
FLUTICASONE PROPIONATE 178 154 18 32
METOPROLOL SUCCINATE 171 168 19 13
DONEPEZIL HCL 156 149 20 30
PREDNISONE 150 133 21 50
NEXIUM 142 97 22 17
LOSARTAN POTASSIUM 136 126 23 21
SPIRIVA 135 134 24 79
FLUOXETINE HCL 132 109 25 61
SERTRALINE HCL 126 99 26 26
ADVAIR DISKUS 118 97 27 62
ZOLPIDEM TARTRATE 111 96 28 18
ATORVASTATIN CALCIUM 108 80 29 12
TAMSULOSIN HCL 103 92 30 29
CARVEDILOL 101 85 31 25
PANTOPRAZOLE SODIUM 93 88 32 35
AZITHROMYCIN 91 69 33 33
AMLODIPINE BESYLATE-BENAZEPRIL 86 80 34 55
BUPROPION HCL SR 85 38 35 233
ALLOPURINOL 85 85 35 37
LANTUS 85 56 35 44
QUETIAPINE FUMARATE 82 70 38 74
PROAIR HFA 82 66 38 64
CRESTOR 80 78 40 20
PAROXETINE HCL 75 35 41 78
GLIPIZIDE 75 59 41 49
CYCLOBENZAPRINE HCL 75 46 R 41 53
ALENDRONATE SODIUM 69 69 44 22
TRAZODONE HCL 66 61 45 42
PROPRANOLOL HCL 60 28 46 169
CIPROFLOXACIN HCL 59 52 47 43
CLOPIDOGREL 58 48 48 31
FAMOTIDINE 57 46 49 82
CARBIDOPA-LEVODOPA 53 53 50 116
TRAMADOL HCL 53 40 50 15
AGGRENOX 53 41 50 198
CYMBALTA 52 33 53 48
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 39 54 68
JANUVIA 51 51 54 52
ZETIA 50 50 56 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.